Biblioteca En este apartado se irán dando a conocer publicaciones científicas de interés en el campo de la Radiofarmacia An overview of current phase 3 radiopharmaceutical therapy clinical trials Ver Detalle Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia Ver Detalle Radiopharmaceuticals and their applications in medicine Ver Detalle Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I Ver Detalle Alpha Atlas: Mapping global production of alpha-emmiting radionuclides for targeted alpha therapy Ver Detalle Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography Ver Detalle GMP-Compliant Automated Radiolabeling and Quality Controls of [68Ga]Ga-FAPI-46 for Fibroblast Activation Protein-Targeted PET Imaging in Clinical Settings Ver Detalle Bismuth chelation for targeted alpha therapy: Current state of the art Ver Detalle Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides Ver Detalle Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation? Ver Detalle End of content No more articles to load
Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia Ver Detalle
Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I Ver Detalle
Alpha Atlas: Mapping global production of alpha-emmiting radionuclides for targeted alpha therapy Ver Detalle
GMP-Compliant Automated Radiolabeling and Quality Controls of [68Ga]Ga-FAPI-46 for Fibroblast Activation Protein-Targeted PET Imaging in Clinical Settings Ver Detalle
Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation? Ver Detalle